The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
作者信息
Cashin C H, Sutton S
出版信息
Br J Pharmacol. 1973 Mar;47(3):658P-659P.
Abstract
摘要
相似文献
1
2
Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.大鼠中由α-甲基对酪氨酸诱导的僵住症、镇静和体温过低。用于筛选对中枢儿茶酚胺能受体有活性的药物的理想工具。
Pharmakopsychiatr Neuropsychopharmakol. 1973 May;6(3):137-57. doi: 10.1055/s-0028-1094377.
3
Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.会议论文：CB 154（2-溴-α-麦角隐亭，溴隐亭），一种潜在的抗帕金森病药物。
Naunyn Schmiedebergs Arch Pharmacol. 1974;282(Suppl):suppl 282:R40.
4
Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.新型金刚烷衍生物1,3 - 二甲基 - 5 - 氨基金刚烷的药理作用
Eur J Pharmacol. 1974 Apr;26(1):9-14. doi: 10.1016/0014-2999(74)90067-3.
5
FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats.FK506作为左旋多巴治疗利血平诱导的大鼠僵住症的有效辅助药物。
Indian J Exp Biol. 2003 Nov;41(11):1264-8.
6
Interaction of anticholinergic agents with -methyl-p-tyrosine and (+)-amphetamine.抗胆碱能药物与α-甲基-对-酪氨酸和（+）-苯丙胺的相互作用。
Br J Pharmacol. 1972 May;45(1):170P-171P.
7
On the interaction between neuroleptics and antiparkinson drugs.论抗精神病药物与抗帕金森病药物之间的相互作用。
Mod Probl Pharmacopsychiatry. 1970;5:50-4.
8
Dopaminergic agonists in animal models of parkinsonism.帕金森病动物模型中的多巴胺能激动剂
Adv Neurol. 1975;9:327-35.
9
Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.新型胆碱能离子通道激动剂SIB - 1765F与左旋多巴在大鼠利血平诱导的帕金森病模型中的相互作用
J Pharmacol Exp Ther. 1997 Jan;280(1):393-401.
10
Anticataleptic action of psychostimulating drugs and serotonin in brain.精神兴奋药物和血清素在大脑中的抗惊厥作用。
Acta Physiol Pol. 1979 Sep-Dec;30(5-6):589-95.
引用本文的文献
1
Small Molecule Regulators of Ferroptosis.铁死亡小分子调节剂。
Adv Exp Med Biol. 2021;1301:81-121. doi: 10.1007/978-3-030-62026-4_6.
2
Monoamine reuptake inhibitors in Parkinson's disease.单胺再摄取抑制剂在帕金森病中的应用。
Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25.
3
Effect of muscimol, a central GABA receptor agonist, on the catalepsy, striatal homovanillic acid increase, and analgesia induced by pilocarpine in rats.中枢γ-氨基丁酸（GABA）受体激动剂蝇蕈醇对毛果芸香碱诱导的大鼠僵住症、纹状体高香草酸增加及镇痛作用的影响。
Psychopharmacology (Berl). 1981;74(4):393-4. doi: 10.1007/BF00432756.
4
Responses of neurones in the cerebral cortex and caudate nucleus to amantadine, amphetamine and dopamine.大脑皮层和尾状核中神经元对金刚烷胺、苯丙胺和多巴胺的反应。
Br J Pharmacol. 1976 Jan;56(1):101-10. doi: 10.1111/j.1476-5381.1976.tb06964.x.
5
Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.阿扑吗啡对胃复安诱导的僵住症的抑制作用及纹状体高香草酸含量的增加。
Br J Pharmacol. 1975 Nov;55(3):381-5. doi: 10.1111/j.1476-5381.1975.tb06941.x.
6
Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.美加明对大鼠脑纹状体和中脑边缘区多巴胺代谢的影响；与吗啡和氟哌啶醇的相互作用。
Br J Pharmacol. 1978 Feb;62(2):213-8. doi: 10.1111/j.1476-5381.1978.tb08448.x.
7
Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.毒蕈碱型胆碱能药物对吗啡诱导的僵住症、抗伤害感受及脑多巴胺代谢变化的影响。
Psychopharmacology (Berl). 1977 Mar 23;52(1):7-15. doi: 10.1007/BF00426593.
本文引用的文献
1
The effect of some psychoactive drugs on central monoamine neurons.某些精神活性药物对中枢单胺能神经元的作用。
Eur J Pharmacol. 1967 Sep;1(5):363-8. doi: 10.1016/0014-2999(67)90096-9.
2
Effect of some amphetamine analogues on -methyl-p-tyrosine-induced catalepsy in rats.某些苯丙胺类似物对大鼠中甲基对酪氨酸诱发的僵住症的影响。
Br J Pharmacol. 1971 Dec;43(4):877-80. doi: 10.1111/j.1476-5381.1971.tb07227.x.
3
Antagonism by amantadine of prochlorpemazine-induced catalepsy.金刚烷胺对氯丙嗪诱发的僵住症的拮抗作用。
J Pharm Pharmacol. 1970 Jul;22(7):546-7. doi: 10.1111/j.2042-7158.1970.tb10567.x.
Zotero 插件